Status:
UNKNOWN
Hypoxia Imaging With 18F FAZA. Prognostic Impact in Cervical Cancer
Lead Sponsor:
Medical University of Vienna
Conditions:
Uterine Cervical Neoplasms
Eligibility:
FEMALE
18-80 years
Brief Summary
The aim of this study is to visualize the tumor hypoxic tissue, the potential quantitative changes and the biological behavior of cervical carcinoma (primary and / or lymph nodes) before, during and a...
Detailed Description
Introduction Tumor hypoxia has been shown to be a prognostic factor for local progression and prognosis in several types of human cancers (1-4), including cervical carcinoma (5). Distribution of oxyg...
Eligibility Criteria
Inclusion
- First diagnosis of histologically proven cervical cancer FIGO stage IB2 to IVA.
- Treatment intention for the purpose of achieving cure
- Age \< 80 years
- No previous standard or radical hysterectomy
Exclusion
- Pregnancy, breast-feeding women, patients that are not able to lie motionless for one hour.Palliative treatment, recurrent disease, neoadjuvant chemotherapy, other pre-existing malignancies, age \> 80 years,
Key Trial Info
Start Date :
July 1 2006
Trial Type :
OBSERVATIONAL
End Date :
July 1 2007
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00388687
Start Date
July 1 2006
End Date
July 1 2007
Last Update
October 17 2006
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Universitiy of Vienna
Vienna, Austria, 1090
2
Medical University of Vienna
Vienna, Austria, 1090